Shamburg News · 8-K filed Nov 18, 2026, 4:01 PM EST
Phathom Pharmaceuticals VP Finance and Principal Accounting Officer Robert Breedlove to Resign
PHAT · Phathom Pharmaceuticals, Inc.
- Leadership change
- Materiality: medium
On November 12, 2026, Robert Breedlove, Vice President, Finance and principal accounting officer of Phathom Pharmaceuticals, Inc., notified the Company of his decision to resign, effective December 4, 2026. He will continue to serve in his role through that date. The filing states the resignation was not the result of any disagreement with the Company on its operations, policies or practices.
Source: SEC EDGAR, Form 8-K, Item 5.02, accession 0001193125-26-467065.
Written from the filing by Shamburg Markets. Figures are as reported by the company.